🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

109+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 20 of 109 recruiting trials for “Amyotrophic lateral sclerosis

RecruitingNCT07502677

Diagnostic Accuracy of SleepImage Technology for Detecting Respiratory Failure in Patients With Amyotrophic Lateral Sclerosis

🏥 Royal Brompton & Harefield NHS Foundation Trust📍 1 site📅 Started Mar 2026View details ↗
Phase 2, PHASE3Enrolling by InvitationNCT07410806

HEALEY ALS Platform Trial - Regimen I NUZ-001

👨‍⚕️ Merit Cudkowicz, MD, Massachusetts General Hospital📍 1 site📅 Started Feb 2026View details ↗
NAEnrolling by InvitationNCT07298486

Impact of Robotic Glove Use on Quality of Life, Grip Strength and Fine Motor Control in ALS

👨‍⚕️ Kayla Chomko, PT, DPT, Nova Southeastern University📍 1 site📅 Started Feb 2026View details ↗
NARecruitingNCT07187388

Investigating the Impact of Electrical Stimulation on Facial Pain, Jaw Movement and Oral Health in People With Motor Neuron Disease.

🏥 Nova Southeastern University📍 1 site📅 Started Jan 2026View details ↗
RecruitingNCT07233148

Healing ALS Registry Observational Study (HAROS)

👨‍⚕️ William L Cowden, MD, Chair of Scientific Board of Academy of Comprehensive Integrative Medicine, Co-chair of Medical Advisory Team of Healing ALS📍 1 site📅 Started Jan 2026View details ↗
Phase 1RecruitingNCT07401121

Safety and Tolerability Study of CTx1000 In Participants With Amyotrophic Lateral Sclerosis

🏥 Celosia Therapeutics Pty Ltd📍 1 site📅 Started Jan 2026View details ↗
Phase 1RecruitingNCT07290062

A Study to Investigate the Safety and Pharmacodynamics of a Single Intrathecal Injection (IT) of INS1202 in Participants With Amyotrophic Lateral Sclerosis (ALS)

🏥 Insmed Gene Therapy LLC📍 3 sites📅 Started Jan 2026View details ↗
NARecruitingNCT07407725

Clinical Outcome Assessment for AT & BCI

🏥 Shirley Ryan AbilityLab📍 1 site📅 Started Jan 2026View details ↗
NARecruitingNCT07357428

Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)

🏥 Paradromics📍 1 site📅 Started Jan 2026View details ↗
Phase 2RecruitingNCT07294144

Tofersen in Non-SOD1 ALS

🏥 Washington University School of Medicine📍 1 site📅 Started Dec 2025View details ↗
NARecruitingNCT07341984

A Physiotherapy Intervention Study in Patients With Amyotrophic Lateral Sclerosis (ALS)

🏥 Charlotte Vogt📍 1 site📅 Started Dec 2025View details ↗
Phase 4RecruitingNCT07223723

A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Chinese Participants With SOD-1 Amyotrophic Lateral Sclerosis (ALS)

👨‍⚕️ Medical Director, Biogen📍 1 site📅 Started Dec 2025View details ↗
Phase 1, PHASE2RecruitingNCT07414212

Evaluation of the Combined Therapy of EH-301 and N-acetylcysteine Together With Riluzole in Amyotrophic Lateral Sclerosis (ALS)

🏥 Biogipuzkoa Health Research Institute📍 1 site📅 Started Nov 2025View details ↗
Phase 2RecruitingNCT07142291

PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS

🏥 PhenoNet, Inc.📍 12 sites📅 Started Nov 2025View details ↗
NARecruitingNCT06828523

Assessing Perceptual Effects of Interactive Tasks

👨‍⚕️ Jimin Lee, Ph.D., The Pennsylvania State University📍 1 site📅 Started Oct 2025View details ↗
NARecruitingNCT07224256

VOICE: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for Communication Restoration

👨‍⚕️ Nader Pouratian, MD, University of Texas Southwestern Medical Center📍 1 site📅 Started Oct 2025View details ↗
Phase 2RecruitingNCT07161999

Study of COYA 302 for the Treatment of ALS

🏥 Coya Therapeutics📍 24 sites📅 Started Oct 2025View details ↗
RecruitingNCT07302321

Needs of ALS Patients With C9orf72 Mutation and Their Caregivers

🏥 Istituto Auxologico Italiano📍 3 sites📅 Started Oct 2025View details ↗
Enrolling by InvitationNCT06841341

Electrophysiology and Ultrasound of Respiratory Muscles and Respective Nerves to Predict Respiratory Insufficiency in ALS

🏥 Jagiellonian University📍 1 site📅 Started Sep 2025View details ↗
Phase 1RecruitingNCT07100119

A Study of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis

👨‍⚕️ Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST), Eli Lilly and Company📍 12 sites📅 Started Aug 2025View details ↗
Page 1 of 6Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →